How Radius Residential Care Limited makes money

Where RAD’s revenue went in FY2023: operating costs, depreciation, interest and tax, and what was left as net loss. Built from the income statement in the filed annual report, and drawn only when the figures reconcile with each other. RAD company profile

How Radius Residential Care Limited makes money — FY2023

Revenue $146.3m · EBITDA $14.2m (9.7% of revenue) · Net loss $2.1m (-1.4% of revenue) · Balance date 31 March 2023

Radius Residential Care Limited (RAD) FY2023: where revenue of $146.3m wentRevenue → EBITDA: $14.2mRevenue → Operating costs (net of other income): $132.1mEBITDA → EBIT: $4.2mEBITDA → Depreciation & amortisation: $10.0mEBIT → Interest: $4.2mIncome tax credit → Interest: $878kOther items (net gain) → Interest: $5.3mNet loss → Interest: $2.1mRevenue: $146.3mRevenue$146.3mEBITDA: $14.2mEBITDA$14.2mOperating costs (net of other income): $132.1m (derived)Operating costs (net ofother income)$132.1m · derivedEBIT: $4.2mEBIT$4.2mDepreciation & amortisation: $10.0mDepreciation &amortisation$10.0mIncome tax credit: $878kIncome tax credit$878kOther items (net gain): $5.3m (balancing item)Other items (net gain)$5.3m · balancingNet loss: $2.1mNet loss$2.1mInterest: $12.5mInterest$12.5m

Band widths are proportional to NZD amounts. Dashed outlines mark derived figures; the hatched node is a balancing item (net profit less every line above it).

Radius Residential Care Limited FY2023 figures used in the chart
FY2023AmountStatusNote
Revenue$146.3mReported
Operating costs (net of other income)−$132.1mDerived *Reported operating expenses $153m do not reconcile; not used.
EBITDA$14.2mReported
Depreciation & amortisation−$10.0mReported
EBIT$4.2mReported
Interest (net finance costs)−$12.5mReported
Income tax credit+$878kReported
Other items (net gain)+$5.3mBalancing item *Net profit less the lines above; covers fair-value movements, impairments, associates and anything else not itemised.
Net loss-$2.1mReported
  • * operating costs: $132.1m = Revenue − EBITDA
Checks run on these figures (6)
  • Passed: Revenue is within the scale of a column stored in thousands.
  • Passed: Revenue in the income statement ($146.3m) vs the summary table ($146.3m): agree within 2%.
  • Passed: EBITDA − D&A = $4.2m vs reported EBIT $4.2m: reconciles.
  • Not met: Reported operating expenses ($153m) leave -$6.7m, not EBITDA of $14.2m (gap -$20.9m); costs derived as revenue minus operating profit instead. No split is shown.
  • Passed: Balancing item $5.3m is 3.6% of revenue (limit 25%).
  • Not met: No operating segments recorded for this year.

Figures extracted automatically from the annual report; check against the report. NZD thousands as stored, shown in millions. Source: annual_report_pdf · method: claude_haiku_pdf · extracted 7 March 2026.

Annual report: FY23 Annual Report (PDF, NZX)

Year-on-year EBITDA bridge (FY2022 → FY2023)

Bridge not available: FY2022 is not charted: EBIT is $0m. This layout does not draw an operating loss.

Margins over time

EBITDA, EBIT and net profit as a share of revenue for each year whose figures passed the checks (7 of 9 years from FY2018). The shaded line is the median of 11 other listed Healthcare operating companies, using each one’s same financial year where it passed the checks; the number of companies in each median is in the table. Gaps are years that were not charted.

EBITDA margin
RAD ebitda margin by financial year, with peer median-10%10%30%FY18FY20FY22FY24FY26FY2018: RAD 8.6%; peer median 26.1% (2)FY2019: not charted — not from annual reportFY2020: RAD 8.9%; peer median 9.7% (3)FY2021: RAD 19.1%; peer median 16.8% (3)FY2022: not charted — operating lossFY2023: RAD 9.7%; peer median 15.0% (5)FY2024: RAD 12.2%; peer median 13.4% (7)FY2025: RAD 13.2%; peer median 15.0% (6)FY2026: RAD 13.5%; peer median 10.3% (2)
EBIT margin
RAD ebit margin by financial year, with peer median-10%10%30%FY18FY20FY22FY24FY26FY2018: RAD 5.6%; peer median 27.5% (3)FY2019: not charted — not from annual reportFY2020: RAD 5.6%; peer median 20.1% (5)FY2021: RAD 9.7%; peer median 9.5% (5)FY2022: not charted — operating lossFY2023: RAD 2.9%; peer median 11.5% (5)FY2024: RAD 6.4%; peer median 10.8% (7)FY2025: RAD 7.4%; peer median 13.2% (6)FY2026: RAD 7.0%; peer median 8.9% (2)
Net margin
RAD net margin by financial year, with peer median-10%10%30%FY18FY20FY22FY24FY26FY2018: RAD 3.8%; peer median 19.4% (3)FY2019: not charted — not from annual reportFY2020: RAD 3.9%; peer median 12.0% (5)FY2021: RAD 1.4%; peer median 3.7% (5)FY2022: not charted — operating lossFY2023: RAD -1.4%; peer median 6.2% (5)FY2024: RAD -5.0%; peer median 6.2% (7)FY2025: RAD 4.0%; peer median 14.4% (6)FY2026: RAD 4.7%; peer median 5.1% (2)

RAD   peer median   below the axis: year not charted (reason in the table). All panels share one scale.

RAD margins by year with peer medians
YearEBITDA margin: RAD · peer median (n)EBIT margin: RAD · peer median (n)Net margin: RAD · peer median (n)Note
FY20188.6%26.1% (2)5.6%27.5% (3)3.8%19.4% (3)
FY2019—11.7% (4)—7.2% (5)—3.9% (5)Not charted: not from annual report
FY20208.9%9.7% (3)5.6%20.1% (5)3.9%12.0% (5)
FY202119.1%16.8% (3)9.7%9.5% (5)1.4%3.7% (5)
FY2022—23.7% (5)—19.4% (5)—10.7% (5)Not charted: operating loss
FY20239.7%15.0% (5)2.9%11.5% (5)-1.4%6.2% (5)
FY202412.2%13.4% (7)6.4%10.8% (7)-5.0%6.2% (7)
FY202513.2%15.0% (6)7.4%13.2% (6)4.0%14.4% (6)
FY202613.5%10.3% (2)7.0%8.9% (2)4.7%5.1% (2)

Peer medians use only peer-years that passed the same checks; a median of fewer than two companies is not shown. Years are grouped by financial-year label, and year-end months differ between companies.

Not yet available: where the cash goes (operating cash flow to capex, dividends and debt) and underlying versus reported earnings. The figures they need are not yet validated.

Years not charted

These years are on file but their figures did not pass the checks, so no chart is drawn for them.

  • FY2022: EBIT is $0m. This layout does not draw an operating loss.
  • FY2019: Figures were not read from a filed annual report (source: not recorded).

All companies with a chart

Data sourced from NZX company annual reports (income statements). Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz.

For informational purposes only. Not investment advice.

Get NZX governance insights in your inbox

Weekly digest of board changes, insider trades, and market signals. No spam. Unsubscribe anytime.